UBS analysts told investors in a note Friday that the market impact of President Donald Trump’s threatened 35% tariff on Canadian imports could be muted, provided key exemptions under the ...

The global pharmaceutical industry is on high alert as US President Donald Trump renews his threat to impose sweeping 200 per cent tariffs on imported pharmaceutical products. The unprecedented ...

President Donald Trump late Thursday threatened a 35% tariff on goods imported from Canada, a dramatic escalation in an ...

Brazil's government expects the 50% tariff U.S. President Donald Trump announced earlier this week on all goods from the ...

Two Oregon lawmakers have launched a bipartisan caucus to promote trade, business development and international economic ...

President Donald Trump’s shock-and-awe tariff campaign is off to a slow start when it comes to reviving American ...

The central bank remains cautious, even as calls for rate cuts grow louder from the White House and other policymakers.

Amidst Trump's calls for lower interest rates, the Federal Reserve is expected to maintain its current monetary policy due to ...

Plus, the Justice Department has subpoenaed 20 doctors and clinics involved in “performing transgender medical procedures on ...

The latest target is Canada, which on Thursday Trump said will face a 35% duty, while most other trading partners will get ...

Blunt letters dictating terms posted to social media and changes late in negotiations have left trading partners wondering what President Trump will do next.

S&P 500 E-Mini futures (ESU25) are trending down -0.62% this morning as sentiment took a hit after U.S. President Donald Trump ratcheted up trade tensions yet again. Late Thursday, President Trump ...